-
-
-
-
-
-
-
U.S. biopharma earnings: Eli Lilly (LLY), Pfizer (PFE) take the stage
-
-
-
-
-
-
-
Moderna Reports First Quarter 2026 Financial Results and Provides Business Updates
-
-
-
-
-
-
-
This U.S. biotech stock is Bernstein's Top Pick for 2026
-
-
-
-
-
-
-
Bernstein Reiterates Market Perform Rating on Moderna (MRNA)
-
-
-
-
-
-
-
Moderna (MRNA) PT Lowered to $18 at Leerink Partners
-
-
-
-
-
-
-
Moderna Reports First Quarter 2025 Financial Results and Provides Business Updates
-
-
-
-
-
-
-
Moderna to Report Fourth Quarter and Full Year 2024 Financial Results on Friday, February 14, 2025
-
1,233,726 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


